FR2845993B1 - PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES - Google Patents

PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES

Info

Publication number
FR2845993B1
FR2845993B1 FR0212886A FR0212886A FR2845993B1 FR 2845993 B1 FR2845993 B1 FR 2845993B1 FR 0212886 A FR0212886 A FR 0212886A FR 0212886 A FR0212886 A FR 0212886A FR 2845993 B1 FR2845993 B1 FR 2845993B1
Authority
FR
France
Prior art keywords
pde5
compositions containing
smooth muscle
therapeutic uses
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0212886A
Other languages
French (fr)
Other versions
FR2845993A1 (en
Inventor
Claire Renee Jeanne Mo Lugnier
Tcheudji Jacques Kameni
Luc Lebeau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Louis Pasteur Strasbourg I
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Louis Pasteur Strasbourg I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Louis Pasteur Strasbourg I filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0212886A priority Critical patent/FR2845993B1/en
Priority to PCT/FR2003/003017 priority patent/WO2004035584A1/en
Priority to AU2003288318A priority patent/AU2003288318A1/en
Publication of FR2845993A1 publication Critical patent/FR2845993A1/en
Application granted granted Critical
Publication of FR2845993B1 publication Critical patent/FR2845993B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
FR0212886A 2002-10-16 2002-10-16 PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES Expired - Fee Related FR2845993B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0212886A FR2845993B1 (en) 2002-10-16 2002-10-16 PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES
PCT/FR2003/003017 WO2004035584A1 (en) 2002-10-16 2003-10-13 Pharmaceutical compounds specifically inhibiting smooth muscle pde5, pharmaceutical compositions containing same and therapeutic uses thereof
AU2003288318A AU2003288318A1 (en) 2002-10-16 2003-10-13 Pharmaceutical compounds specifically inhibiting smooth muscle pde5, pharmaceutical compositions containing same and therapeutic uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212886A FR2845993B1 (en) 2002-10-16 2002-10-16 PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES

Publications (2)

Publication Number Publication Date
FR2845993A1 FR2845993A1 (en) 2004-04-23
FR2845993B1 true FR2845993B1 (en) 2005-02-11

Family

ID=32050450

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0212886A Expired - Fee Related FR2845993B1 (en) 2002-10-16 2002-10-16 PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES

Country Status (3)

Country Link
AU (1) AU2003288318A1 (en)
FR (1) FR2845993B1 (en)
WO (1) WO2004035584A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202043234A (en) 2019-01-24 2020-12-01 美商普羅米修斯生物科學股份有限公司 Gpr35 modulators
TW202219047A (en) * 2020-07-23 2022-05-16 美商普羅米修斯生物科學股份有限公司 Therapeutic agents targeting gpr35

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001439A1 (en) * 1997-07-03 1999-01-14 Du Pont Pharmaceuticals Company Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
WO1999002161A1 (en) * 1997-07-09 1999-01-21 Forssmann Wolf Georg Use of phosphordiesterase inhibitors in the treatment of prostatic diseases
DE19838705A1 (en) * 1998-08-26 2000-03-02 Bayer Ag New dihydro- (1,2,3) -triazolo- [4,5-d] pyrimidin-7-ones

Also Published As

Publication number Publication date
AU2003288318A1 (en) 2004-05-04
WO2004035584A1 (en) 2004-04-29
AU2003288318A8 (en) 2004-05-04
FR2845993A1 (en) 2004-04-23

Similar Documents

Publication Publication Date Title
ATE464049T1 (en) PHARMACEUTICAL COMBINATIONS OF HYDROCODONE AND NALTREXONE
IS7552A (en) Benzotrelated heteroaryl amide derivatives of thienopyridine useful as therapeutic agents, pharmaceutical compositions containing them and methods of their use
CY2013043I1 (en) 4-OXOQUINOLINE COMPOUNDS AND THEIR USE AS INHIBITORS OF HIV INTEGRATION
PL357856A1 (en) Pharmaceutical granules containing tamsulozine and method of their manufacture
EP1483277A4 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
FR2847253B1 (en) NOVEL DERIVATIVES OF PYRIDAZINONES AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
HK1088543A1 (en) Pharmaceutical compositions and dosage forms of thalidomide
NO20062504L (en) Compositions and dosage forms for improved absorption
FIU20070322U0 (en) Pharmaceutical preparation containing oxycodone and naloxone
IL190218A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
HRP20040849A2 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
HUP0203813A3 (en) Aminobenzophenones as inhibitors of il-1betha and tnf-alpha, pharmaceutical compositions containing them and their use
FR2834459B1 (en) MICROBICIDE AGENT AND COSMETIC TREATMENT COMPOSITION CONTAINING THE SAME
HUP0300917A2 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and pharmaceutical compositions containing them
ZA200500203B (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
PL361518A1 (en) Application of substance and pharmaceutical composition
DE60137069D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING MODAFINE COMPOUNDS
WO2006059194A3 (en) Pharmaceutical sustained-release composition containing clozapine
IL163959A (en) Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them
EP1849468A3 (en) Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
FR2845993B1 (en) PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES
FR2846327B1 (en) N-BENZODIOXOLYL, N-BENZODIOXANYL AND N-BENZODIOXEPINYL ARYLCARBOXAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF DYSLIPIDEMIA AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
AU2003256157A1 (en) Oral dosage forms of water insoluble drugs and methods of making the same
AU2003295713A8 (en) Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
AU2003231019A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING Alpha3Beta4 NICOTINIC RECEPTOR ANTAGONISTS AND METHODS OF THEIR USE

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060630